Topics

Articles

Acquisition is expected to drive organization’s ‘next phase of growth.’

Private Investment Consortium Purchases Syneos Health for $7.1 Billion

Site expected to support growth of advanced analytics and data science team. 





Beghou Consulting Unveils New India Office

Acquisition of Evolution Road expands company’s omnichannel know-how 

Inizio Obtains Additional ‘Commercial Innovation’ Experience

Stakeholders are investing heavily in their ability to curate appropriate data sets and devise advanced data-analytics capabilities to harness real-world evidence (RWE) across the entire pharma lifecycle—from drug discovery and development through product launch and commercialization

Pharma and RWE: Hitting Its Stride

How to make commercial AI actionable in the last mile, helping to better realize      data science investment and improve customer engagement

'Next-Best-Action' for Data Analytics

How biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients

The Value of ML in Customer Targeting

Product commercialization in Canada is by no means simple, but the end result presents its advantages

What Pharma Companies Need to Know About Entering the Great White North

Healthcare marketing agency acquisition augments company’s commercialization portfolio

Indegene Inks Deal for CultHealth

AZ’s Greg Rossi talks about the company’s oncology activities and his vision for the future of cancer treatment

AstraZeneca: Redefining Cancer Care

With the business model changing and the patent cliff looming, Ashfield Engage's Chris Savage talks about what these upheavals mean for pharma companies, their sales reps, and their patients


Commercial Channels